FULVESTRANT SANDOZ 250 MG INJ SOL ISP 1X5ML + 1J

What is the maximum co-payment for FULVESTRANT SANDOZ?

If the insurance company contributes, the maximum co-payment is 1 808,69 Kč. The maximum pharmacy price is 6 007,31 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but only during an outpatient procedure. When dispensed on prescription, the patient always pays the full price.

Does FULVESTRANT SANDOZ have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

4 198,62 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Fulvestrant je hrazen v léčbě hormonálně dependentního (ER pozitivního) lokálně pokročilého nebo metastatického karcinomu prsu u postmenopauzálních žen:
1) po vyčerpání předchozí léčby tamoxifenem a inhibitory aromatázy (tj. ve 3. linii léčby) při relapsu onemocnění v průběhu nebo po adjuvantní antiestrogenové terapii nebo progresi onemocnění při léčbě antiestrogeny.
2) které nebyly dříve léčeny endokrinní léčbou, pokud jejich stav výkonnosti odpovídá ECOG 0-1 a pokud nejsou onemocněním postiženy viscerální orgány.
Pro oba body platí, že fulvestrant je hrazen do progrese onemocnění či do doby, kdy pacientka léčbu přestane snášet.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe FULVESTRANT SANDOZ?

clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology

What is the composition of FULVESTRANT SANDOZ?

Fulvestrant (250 mg), ethanol 96 % (v/v), benzylalkohol, benzyl-benzoát, panenský ricinový olej (5 ml). More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to FULVESTRANT SANDOZ?

The medicine belongs to ATC group L02BA03 – FULVESTRANT. Medicines with the same active substance can be found here.

Who manufactures FULVESTRANT SANDOZ?

Informace o výrobci není dostupná.

Is the medicine in shortage?

The latest report from the manufacturer is from 11. 3. 2025. Production was terminated with effect from 31. 12. 2025. The manufacturer lists medicines with the following code as a potential substitute: